Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3,4-dihydroxybenzoate | - |
Gallus gallus | |
3,4-dihydroxybenzoate | - |
Homo sapiens | |
Benzyloxycarbonyl-Phe-oxaproline-Gly-benzyl ester | - |
Gallus gallus | |
Benzyloxycarbonyl-Phe-oxaproline-Gly-benzyl ester | - |
Homo sapiens | |
Beta-lactam antibiotics | - |
Gallus gallus | |
Beta-lactam antibiotics | - |
Homo sapiens | |
Coumalic acid | i.e. 2-oxo-1,2H-pyran-5-carboxylic acid | Gallus gallus | |
Coumalic acid | i.e. 2-oxo-1,2H-pyran-5-carboxylic acid | Homo sapiens | |
daunorubicin | - |
Gallus gallus | |
daunorubicin | - |
Homo sapiens | |
doxorubicin | - |
Gallus gallus | |
doxorubicin | - |
Homo sapiens | |
ethylpyridine-2,4-dicarboxylate | - |
Gallus gallus | |
ethylpyridine-2,4-dicarboxylate | - |
Homo sapiens | |
N,N'-diethylpyridine 2,4-dicarboxamide | - |
Gallus gallus | |
N,N'-diethylpyridine 2,4-dicarboxamide | - |
Homo sapiens | |
poly(L-proline) | competitive inhibitors with respect to the polypeptide substrate, the inhibition increases with chain length | Gallus gallus | |
poly(L-proline) | competitive inhibitors with respect to the polypeptide substrate, the inhibition increases with chain length | Homo sapiens | |
poly(L-proline) | - |
Mus musculus | |
Pyridine 2,4-dicarboxylate | - |
Gallus gallus | |
Pyridine 2,4-dicarboxylate | - |
Homo sapiens | |
Pyridine 2,4-dicarboxylate | - |
Mus musculus | |
Pyridine 2,4-dicarboxylate | - |
Volvox carteri | |
Pyridine 2,5-dicarboxylate | - |
Gallus gallus | |
Pyridine 2,5-dicarboxylate | - |
Homo sapiens | |
Pyridine 2,5-dicarboxylate | - |
Volvox carteri | |
Zn2+ | - |
Gallus gallus | |
Zn2+ | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0002 | - |
protocollagen type I L-proline | - |
Gallus gallus | |
0.0002 | - |
protocollagen type I L-proline | - |
Homo sapiens | |
0.05 | - |
(Pro-Pro-Gly)10 | - |
Homo sapiens | |
0.05 | - |
(L-Pro-L-Pro-Gly)10 | - |
Gallus gallus | |
1.8 | - |
(L-Pro-L-Pro-Gly)5 | - |
Gallus gallus | |
1.8 | - |
(L-Pro-L-Pro-Gly)5 | - |
Homo sapiens | |
20 | - |
L-Pro-L-Pro-Gly | - |
Gallus gallus | |
20 | - |
L-Pro-L-Pro-Gly | - |
Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Fe2+ | - |
Mus musculus | |
Fe2+ | - |
Homo sapiens | |
Fe2+ | - |
Volvox carteri | |
Fe2+ | bound: 2 mol/mol | Gallus gallus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
procollagen L-proline + 2-oxoglutarate + O2 | Gallus gallus | the biological substrate for the enzyme is a proline residue in an appropriate sequence of a growing or newly synthesized polypeptide chain | procollagen trans-4-hydroxy-L-proline + succinate + CO2 | - |
? | |
procollagen L-proline + 2-oxoglutarate + O2 | Homo sapiens | the biological substrate for the enzyme is a proline residue in an appropriate sequence of a growing or newly synthesized polypeptide chain | procollagen trans-4-hydroxy-L-proline + succinate + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Gallus gallus | - |
- |
- |
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Volvox carteri | - |
green algae | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(L-Pro-L-Pro-Gly)10 + 2-oxoglutarate + O2 | - |
Gallus gallus | (L-Pro-L-Pro-Gly)10-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
(L-Pro-L-Pro-Gly)5 + 2-oxoglutarate + O2 | - |
Gallus gallus | (L-Pro-L-Pro-Gly)5-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
(L-Pro-L-Pro-Gly)5 + 2-oxoglutarate + O2 | - |
Homo sapiens | (L-Pro-L-Pro-Gly)5-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
(Pro-Pro-Gly)10 + 2-oxoglutarate + O2 | - |
Homo sapiens | ? + succinate + CO2 | - |
? | |
(Pro-Pro-Gly)n + 2-oxoglutarate + O2 | n: 1,5,10 | Gallus gallus | (Pro-4-hydroxy-Pro-Gly)n + succinate + CO2 | n: 1,5,10 | ? | |
(Pro-Pro-Gly)n + 2-oxoglutarate + O2 | n: 1,5,10 | Mus musculus | (Pro-4-hydroxy-Pro-Gly)n + succinate + CO2 | n: 1,5,10 | ? | |
(Pro-Pro-Gly)n + 2-oxoglutarate + O2 | n: 1,5,10 | Homo sapiens | (Pro-4-hydroxy-Pro-Gly)n + succinate + CO2 | n: 1,5,10 | ? | |
2-oxoglutarate + O2 + ascorbate | uncoupled oxidative decarboxylation | Gallus gallus | succinate + dehydroascorbate + CO2 + H2O | - |
? | |
L-Pro-L-Pro-Gly + 2-oxoglutarate + O2 | - |
Gallus gallus | L-Pro-L-Pro-Gly-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
L-Pro-L-Pro-Gly + 2-oxoglutarate + O2 | - |
Homo sapiens | L-Pro-L-Pro-Gly-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
procollagen L-proline + 2-oxoglutarate + O2 | the biological substrate for the enzyme is a proline residue in an appropriate sequence of a growing or newly synthesized polypeptide chain | Gallus gallus | procollagen trans-4-hydroxy-L-proline + succinate + CO2 | - |
? | |
procollagen L-proline + 2-oxoglutarate + O2 | the biological substrate for the enzyme is a proline residue in an appropriate sequence of a growing or newly synthesized polypeptide chain | Homo sapiens | procollagen trans-4-hydroxy-L-proline + succinate + CO2 | - |
? | |
protocollagen type I L-proline + 2-oxoglutarate + O2 | - |
Gallus gallus | protocollagen type I-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r | |
protocollagen type I L-proline+ 2-oxoglutarate + O2 | - |
Homo sapiens | protocollagen type I-trans-4-hydroxy-L-proline + succinate + CO2 | - |
r |
Subunits | Comment | Organism |
---|---|---|
monomer | the algal enzyme is clearly structurally related to the alpha subunit of the vertebrate enzyme | Volvox carteri |
tetramer | characterization of the beta subunit, the beta subunit is a multifunctional polypeptide, having disulfide isomerase activity | Homo sapiens |
tetramer | the tetramer appears to contain one active site per pair of dissimilar subunits, the 2-oxoglutarate and peptide binding sites of the enzyme are located on the alpha subunit, whereas the ascorbate binding site may be built up of both alpha and beta subunits | Gallus gallus |
tetramer | the tetramer appears to contain one active site per pair of dissimilar subunits, the 2-oxoglutarate and peptide binding sites of the enzyme are located on the alpha subunit, whereas the ascorbate binding site may be built up of both alpha and beta subunits | Homo sapiens |
tetramer | there are two forms of the alpha subunit | Gallus gallus |
tetramer | there are two forms of the alpha subunit | Mus musculus |
tetramer | there are two forms of the alpha subunit | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ascorbate | - |
Mus musculus | |
ascorbate | - |
Volvox carteri | |
ascorbate | requirement | Gallus gallus | |
ascorbate | requirement | Homo sapiens | |
ascorbate | oxygen acceptor in the decarboxylation of 2-oxoglutarate without subsequent hydroxylation of peptide substrate | Gallus gallus | |
ascorbate | oxygen acceptor in the decarboxylation of 2-oxoglutarate without subsequent hydroxylation of peptide substrate | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00002 | - |
poly (L-proline) | molecular weight of 15000 | Gallus gallus | |
0.00002 | - |
poly (L-proline) | molecular weight of 15000 | Homo sapiens | |
0.0006 | - |
Zn2+ | - |
Gallus gallus | |
0.0006 | - |
Zn2+ | - |
Homo sapiens | |
0.0008 | - |
Pyridine-2,5-dicarboxylate | - |
Gallus gallus | |
0.0008 | - |
Pyridine-2,5-dicarboxylate | - |
Homo sapiens | |
0.002 | - |
Pyridine-2,4-dicarboxylate | - |
Gallus gallus | |
0.002 | - |
Pyridine-2,4-dicarboxylate | - |
Homo sapiens | |
0.005 | - |
3,4-dihydroxybenzoate | competitive inhibitor with respect to ascorbate | Gallus gallus |